Skip to main content
SpringerLink
Log in

Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage

  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

Abstract

The pharmacokinetics of norfloxacin were studied in six healthy volunteers, and three patients each with moderate renal and hepatic damage. A new specific and sensitive high performance liquid chromatography method was set up to measure plasma and urine concentrations of norfloxacin. The mean urinary concentrations after a single oral dose of 400 mg norfloxacin exceeded many times the MIC and MBC values of most of the bacterial strains responsible for urinary tract infections. Results in the patients with hepatic and renal damage indicated slight and not statistically significant differences in comparison with healthy volunteers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gadebusch, H. H., Koupal, L. R., Celozzi, E., Shungu, D. L., Bland, J., Weissberger, B., Pelak, B. A., Fisch, E., Chung, S. K., Huber, J.: Norfloxacin (MK-366, AM-715), a new orally absorbed synthetic compound for the treatment of bacterial infections. In: Periti, P., Gialdroni Grassi, G.: Current Chemotherapy, Volume 1, American Society for Microbiology, Washington, DC, 1982, p. 351–353.

    Google Scholar 

  2. Hirai, K. A., Ito, Y., Abe, S., Suzue, T., Irikura, M. I., Mitsuhashi, S.: Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections. Antimicrobial Agents and Chemotherapy 1981, 19: 188–189.

    PubMed  Google Scholar 

  3. Ito, A., Hirai, K., Inoue, M., Koga, H., Suzue, S., Irikura, T., Mitsuhashi, S.: In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrobial Agents and Chemotherapy 1980, 17: 103–108.

    PubMed  Google Scholar 

  4. Khan, M. Y., Siddiqui, Y., Gruninger, R. P.: Comparative in vitro activity of MK-366 and other selected oral antimicrobial agents againstNeisseria gonorrhoeae. Antimicrobial Agents and Chemotherapy 1981, 20: 265–266.

    PubMed  Google Scholar 

  5. Newsom, S. W. B., Matthews, J., Amphlett, M., Warren, R. E.: Norfloxacin and the antibacterial gamma pyridone beta carboxylic acids. Journal of Antimicrobial Chemotherapy 1982, 10: 25–30.

    Google Scholar 

  6. Neu, H. C., Labthavikul, P.: In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides and trimethoprim. Antimicrobial Agents and Chemotherapy 1982, 22: 23–27.

    PubMed  Google Scholar 

  7. Khan, M. Y., Gruninger, R. P., Nelson, S. M., Klicker, R. E.: Comparative in vitro activity of norfloxacin (MK-366) and ten other oral antimicrobial agents against urinary bacterial isolates. Antimicrobial Agents and Chemotherapy 1982, 21: 848–851.

    PubMed  Google Scholar 

  8. King, A., Warren, C., Shannon, K., Phillips, I.: In vitro antibacterial activity of norfloxacin (MK-366). Antimicrobial Agents and Chemotherapy 1982, 21: 604–607.

    PubMed  Google Scholar 

  9. Gadebusch, H. H., Shungu, D. L., Weinberg, E., Chung, S. K.: Comparison of the antibacterial activity of norfloxacin (MK-366, AM-715), a new organic acid, with that of other orally absorbed chemotherapeutic agents. Infection 1982, 10: 41–44.

    Article  PubMed  Google Scholar 

  10. Murayama, S., Hirai, K., Ito, A., Abe, Y., Irikura, T.: Studies on absorption, distribution and excretion of AM-715 in animals by the bioassay method. Chemotherapy (Tokyo) 1981, 29, Supplement 4: 98–104.

    Google Scholar 

  11. Nagatsu, Y., Endo, K., Irikura, T.: Studies on the fate of14C-labelled AM-715. Chemotherapy (Tokyo) 1981, 29, Supplement 4: 105–118.

    Google Scholar 

  12. Nagatsu, Y., Endo, K., Irikura, T.: Studies on the metabolism of14C-labelled AM-715. Chemotherapy (Tokyo) 1981, 29, Supplement 4: 119–127.

    Google Scholar 

  13. Ozaki, T., Uchida, H., Irikura, T.: Studies on metabolism of AM-715 in humans by high-performance liquid chromatography. Chemotherapy (Tokyo) 1981, 29, Supplement 4: 128–135.

    Google Scholar 

  14. Abiko, T., Ishihama, A., Ogawa, N., Uchida, H., Murayama, S., Hirai, K., Oomori, Y., Abe, Y., Irikura, T.: Phase I. Study on AM-715. Chemotherapy (Tokyo) 1981, 29, Supplement 4: 129–145.

    Google Scholar 

  15. Gibaldi, M., Perrier, O.: Pharmacokinetics. Marcel Dekker Inc., New York, 1975.

    Google Scholar 

  16. Boppana, V. K., Swanson, B. N.: Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography. Antimicrobial Agents and Chemotherapy 1982, 21: 808–810.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pharmacology, Medical School, University of Turin, Corso Raffaello 30, Turin, Italy

    M. Eandi, I. Viano, L. Leone & E. Genazzani

  2. Infectious Diseases Division, Amedeo di Savoia Hospital, Corso Svizzera 164, Turin, Italy

    F. Di Nola

Authors
  1. M. Eandi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Viano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Di Nola
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Leone
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Genazzani
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eandi, M., Viano, I., Di Nola, F. et al. Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage. Eur. J. Clin. Microbiol. 2, 253–259 (1983). https://doi.org/10.1007/BF02029528

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02029528

Keywords

Search

Navigation